134 related articles for article (PubMed ID: 18637501)
41. HCMV Induces Macropinocytosis for Host Cell Entry in Fibroblasts.
Hetzenecker S; Helenius A; Krzyzaniak MA
Traffic; 2016 Apr; 17(4):351-68. PubMed ID: 26650385
[TBL] [Abstract][Full Text] [Related]
42. The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion.
Biolatti M; Dell'Oste V; De Andrea M; Landolfo S
New Microbiol; 2018 Apr; 41(2):87-94. PubMed ID: 29384558
[TBL] [Abstract][Full Text] [Related]
43. Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infection.
Tsvitov M; Frampton AR; Shah WA; Wendell SK; Ozuer A; Kapacee Z; Goins WF; Cohen JB; Glorioso JC
Virology; 2007 Apr; 360(2):477-91. PubMed ID: 17157347
[TBL] [Abstract][Full Text] [Related]
44. Host cellular signaling induced by influenza virus.
Dai X; Zhang L; Hong T
Sci China Life Sci; 2011 Jan; 54(1):68-74. PubMed ID: 21253874
[TBL] [Abstract][Full Text] [Related]
45. Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.
Cui X; Freed DC; Wang D; Qiu P; Li F; Fu TM; Kauvar LM; McVoy MA
J Virol; 2017 Jul; 91(13):. PubMed ID: 28381568
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms of human cytomegalovirus infection with a focus on epidermal growth factor receptor interactions.
Falcão ASC; da Costa Vasconcelos PF; Lobato da Silva DF; Viana Pinheiro JJ; Falcão LFM; Quaresma JAS
Rev Med Virol; 2017 Nov; 27(6):. PubMed ID: 29024283
[TBL] [Abstract][Full Text] [Related]
47. Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection.
Xu S; Schafer X; Munger J
J Virol; 2016 May; 90(9):4346-4356. PubMed ID: 26889030
[TBL] [Abstract][Full Text] [Related]
48. Cellular receptor for human cytomegalovirus.
Cooper NR; Nowlin D; Taylor HP; Compton T
Transplant Proc; 1991 Jun; 23(3 Suppl 3):56-9, discussion 59. PubMed ID: 1648837
[TBL] [Abstract][Full Text] [Related]
49. Prion protein: a pattern recognition receptor for viral components and uric acid responsible for the induction of innate and adaptive immunity.
McBride SM
Med Hypotheses; 2005; 65(3):570-7. PubMed ID: 15913900
[TBL] [Abstract][Full Text] [Related]
50. Quantitative membrane proteomics reveals a role for tetraspanin enriched microdomains during entry of human cytomegalovirus.
Viswanathan K; Verweij MC; John N; Malouli D; Früh K
PLoS One; 2017; 12(11):e0187899. PubMed ID: 29121670
[TBL] [Abstract][Full Text] [Related]
51. Expanding diversity of glycan receptor usage by rotaviruses.
Coulson BS
Curr Opin Virol; 2015 Dec; 15():90-6. PubMed ID: 26363995
[TBL] [Abstract][Full Text] [Related]
52. Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface.
Weisblum Y; Panet A; Zakay-Rones Z; Vitenshtein A; Haimov-Kochman R; Goldman-Wohl D; Oiknine-Djian E; Yamin R; Meir K; Amsalem H; Imbar T; Mandelboim O; Yagel S; Wolf DG
Virology; 2015 Nov; 485():289-96. PubMed ID: 26318261
[TBL] [Abstract][Full Text] [Related]
53. Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.
Schneider-Ohrum K; Cayatte C; Liu Y; Wang Z; Irrinki A; Cataniag F; Nguyen N; Lambert S; Liu H; Aslam S; Duke G; McCarthy MP; McCormick L
J Virol; 2016 Nov; 90(22):10133-10144. PubMed ID: 27581989
[TBL] [Abstract][Full Text] [Related]
54. Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells.
Jarvis MA; Fish KN; Söderberg-Naucler C; Streblow DN; Meyers HL; Thomas G; Nelson JA
J Virol; 2002 May; 76(10):5147-55. PubMed ID: 11967330
[TBL] [Abstract][Full Text] [Related]
55. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
[TBL] [Abstract][Full Text] [Related]
56. A systemic network triggered by human cytomegalovirus entry.
Wang A; Ren L; Li H
Adv Virol; 2011; 2011():262080. PubMed ID: 22312338
[TBL] [Abstract][Full Text] [Related]
57. The life cycle and pathogenesis of human cytomegalovirus infection: lessons from proteomics.
Jean Beltran PM; Cristea IM
Expert Rev Proteomics; 2014 Dec; 11(6):697-711. PubMed ID: 25327590
[TBL] [Abstract][Full Text] [Related]
58. Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein.
Wille PT; Wisner TW; Ryckman B; Johnson DC
mBio; 2013 Jun; 4(3):e00332-13. PubMed ID: 23736286
[TBL] [Abstract][Full Text] [Related]
59. The immune response to human CMV.
La Rosa C; Diamond DJ
Future Virol; 2012 Mar; 7(3):279-293. PubMed ID: 23308079
[TBL] [Abstract][Full Text] [Related]
60. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.
Cannon MJ; Schmid DS; Hyde TB
Rev Med Virol; 2010 Jul; 20(4):202-13. PubMed ID: 20564615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]